We are live on ! Find out more
CAM

ClariVest Asset Management Portfolio holdings

AUM $980M
1-Year Est. Return 60.89%
This Fund
S&P 500
This Quarter Est. Return
-16.53%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$2.29B
AUM Growth
-$244M
Cap. Flow
+$229M
Cap. Flow %
9.99%
Top 10 Hldgs %
33.68%
Holding
820
New
131
Increased
67
Reduced
326
Closed
128

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$203M
2
AMZN icon
Amazon
AMZN
+$94.4M
3
CI icon
Cigna
CI
+$19.9M
4
KR icon
Kroger
KR
+$18.6M
5
AZO icon
AutoZone
AZO
+$17.6M

Top Sells

Rank Stock Value
1
DKS icon
Dick's Sporting Goods
DKS
+$23.9M
2
DRI icon
Darden Restaurants
DRI
+$15.7M
3
NFLX icon
Netflix
NFLX
+$14.9M
4
GS icon
Goldman Sachs
GS
+$12.6M
5
TXN icon
Texas Instruments
TXN
+$11M

Sector Composition

Rank Sector Weight
1 Technology 36.75%
2 Healthcare 14.04%
3 Consumer Discretionary 12%
4 Communication Services 8.16%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZO icon
401
MarineMax
HZO
$788M
$419K 0.02%
11,600
IPI icon
402
Intrepid Potash
IPI
$469M
$416K 0.02%
9,200
+3,600
+64% +$262K
APPN icon
403
Appian
APPN
$2.48B
$408K 0.02%
8,622
NTLA icon
404
Intellia Therapeutics
NTLA
$1.67B
$408K 0.02%
7,894
KZR
405
DELISTED
Kezar Life Sciences
KZR
$400K 0.02%
+4,840
New +$427K
MDXG icon
406
MiMedx Group
MDXG
$633M
$398K 0.02%
114,592
-1,649
-1% -$6.46K
APPS icon
407
Digital Turbine
APPS
$1.74B
$393K 0.02%
22,502
-40,711
-64% -$1.1M
ITOS
408
DELISTED
iTeos Therapeutics
ITOS
$392K 0.02%
+19,000
New +$451K
CBAY
409
DELISTED
Cymabay Therapeutics
CBAY
$392K 0.02%
133,000
CSBR icon
410
Champions Oncology
CSBR
$72.1M
$386K 0.02%
48,200
HBIO icon
411
Harvard Bioscience
HBIO
$29.2M
$385K 0.02%
10,710
-120
-1% -$5.42K
PLYA
412
DELISTED
Playa Hotels & Resorts
PLYA
$378K 0.02%
+55,118
New +$458K
RGNX icon
413
Regenxbio
RGNX
$708M
$375K 0.02%
15,168
VERI icon
414
Veritone
VERI
$122M
$372K 0.02%
57,046
NEX
415
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$370K 0.02%
+38,855
New +$408K
ICHR icon
416
Ichor Holdings
ICHR
$2.56B
$369K 0.02%
14,200
-23,326
-62% -$676K
COHU icon
417
Cohu
COHU
$2.5B
$358K 0.02%
12,888
SRTS icon
418
Sensus Healthcare
SRTS
$50.5M
$355K 0.02%
46,300
SITM icon
419
SiTime
SITM
$21.8B
$346K 0.02%
2,122
EDIT icon
420
Editas Medicine
EDIT
$442M
$337K 0.01%
28,495
+9,998
+54% +$134K
IBRX icon
421
ImmunityBio
IBRX
$8.1B
$335K 0.01%
90,151
+36,424
+68% +$146K
ASTH icon
422
Astrana Health
ASTH
$1.77B
$333K 0.01%
8,636
CDXS icon
423
Codexis
CDXS
$158M
$330K 0.01%
31,431
STKS icon
424
The ONE Group
STKS
$53M
$326K 0.01%
44,173
VNDA icon
425
Vanda Pharmaceuticals
VNDA
$302M
$320K 0.01%
29,400

Similar funds

ClariVest Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, ClariVest Asset Management held 820 positions worth $2.29B, down 9.6% from $2.54B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ClariVest Asset Management deployed $229M of net new capital in Q2 2022, opening 131 new positions and adding to 67 existing holdings. Its largest new stake was Apple: 1,338,227 shares worth $183M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Dick's Sporting Goods, an estimated $23.9M trimmed.

  • ClariVest Asset Management's largest Q2 2022 buy was Apple: 1,338,227 shares worth $183M.
  • ClariVest Asset Management added most to Cigna in Q2 2022, an estimated $19.9M increase.
  • ClariVest Asset Management's biggest Q2 2022 reduction was Dick's Sporting Goods, cutting an estimated $23.9M.
  • ClariVest Asset Management fully exited Darden Restaurants in Q2 2022, selling an estimated $15.7M.
  • ClariVest Asset Management's ten largest holdings make up 34% of its $2.29B portfolio in Q2 2022.
  • ClariVest Asset Management opened 131 new positions and closed 128 in Q2 2022.
  • ClariVest Asset Management's portfolio value fell 9.6% quarter-over-quarter to $2.29B.

Based on ClariVest Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.